ArticleHeliyon2024

Real-world clinical results of CGRP monoclonal antibody treatment for medication overuse headache of migraine without abrupt drug discontinuation and no hospitalization.

Takafumi Tanei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.